Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders
- 1 May 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 137 (5) , 625-632
- https://doi.org/10.1001/archinte.137.5.625
Abstract
Research from JAMA Internal Medicine — Clinical Significance of Circulating C-Peptide in Diabetes Mellitus and Hypoglycemic DisordersThis publication has 9 references indexed in Scilit:
- Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urineDiabetes, 1977
- Abnormalities of endogenous glucagon and insulin in unstable diabetesDiabetes, 1977
- Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivityThe Journal of Pediatrics, 1977
- Circadian variation of serum glucose, C-peptide immunoreactivity and free insulin in normal and insulin-treated diabetic pregnant subjectsDiabetologia, 1976
- Circulating Serum C-PeptideNew England Journal of Medicine, 1976
- Production of Antisera to Synthetic Benzyloxycarbonyl-C-peptide of Human ProinsulinHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1976
- Plasma C-Peptide and Diagnosis of Factitious HyperinsulinismAnnals of Internal Medicine, 1975
- Spontaneous Hypoglycemia with Insulin Autoimmunity in Graves' DiseaseAnnals of Internal Medicine, 1974
- Diabetic Ketoacidosis Associated with Mumps Virus InfectionAnnals of Internal Medicine, 1973